NOVONIX Ltd

NOVONIX Limited has applied for the quotation of 129,334,163 new ordinary fully paid securities on the ASX. These shares were issued on June 22, 2026, at an issue price of AUD 0.16 per security, as part of a previously announced placement. Following this quotation, the company's total quoted ordinary fully paid securities will amount to 991,561,920, with additional shares still to be issued under a securities purchase plan.

NOVONIX Limited has opened its Share Purchase Plan (SPP), allowing eligible shareholders to subscribe for up to A$30,000 worth of new shares at an issue price of A$0.16 per share. This price represents a 33.3% discount to the closing price on June 15, 2026, and a 31.2% discount to the five-day volume-weighted average price. The company aims to raise A$3.0 million through the SPP, with proceeds, combined with a recent A$20.7 million institutional placement, earmarked for capital expenditure to boost production capacity and meet customer demand.

NOVONIX Limited announced a successful A$20.7 million institutional placement and the launch of a Share Purchase Plan (SPP) aimed at raising an additional A$3.0 million. The capital raised at A$0.16 per share, a discount to market prices, will fund capital expenditure for production capacity expansion to meet growing customer demand. Bell Potter Securities Limited served as the Lead Manager for the placement.

NOVONIX Limited announced the delivery of a mass production qualification sample (C-sample) of synthetic graphite anode active material to its lead customer, Panasonic Energy. This milestone represents the first known delivery of such a sample produced in North America, significantly advancing the establishment of a U.S. battery materials supply chain. While NOVONIX's internal tests show the material meets Panasonic's specifications, formal validation by Panasonic is pending. The company reaffirms its expectation for mass production for Panasonic to commence in the second half of 2027, subject to successful qualification.

NOVONIX Limited announced the delivery of a mass production qualification sample (C-sample) of synthetic graphite anode active material (AAM) to its lead customer, Panasonic Energy. This milestone marks the first known delivery of a Synthetic Graphite AAM C-sample produced in North America, representing a critical step towards establishing a U.S. supply chain. The company's testing shows the material meets all Panasonic's required specifications, though formal validation remains subject to Panasonic’s assessment. NOVONIX reaffirms its expectation for mass production for Panasonic to begin in the second half of 2027, subject to successful completion of the qualification process.

NOVONIX Limited announced that Chief Financial Officer Robert Long will be leaving the company in July 2026 to pursue other opportunities. To ensure a smooth transition, current Chair Ron Edmonds has agreed to assume the role of Interim Chief Financial Officer while the company searches for a permanent replacement. During this period, Deputy Chair Admiral Robert Natter will resume the role of Chair.

NOVONIX Limited announced the cessation of 2,932,881 performance rights (ASX code NVXAD) on May 27, 2026. These rights lapsed because the conditions for their vesting were not met or became incapable of being satisfied. The company did not pay any consideration for this cessation, resulting in a revised total of 27,401,382 unquoted performance rights remaining on issue.

NOVONIX Ltd announced the quotation of 784,817 new ordinary fully paid shares on the ASX, effective May 13, 2026. These shares were issued as a result of the vesting of employee performance rights, with 4,687,512 performance rights being converted. The new shares will rank equally with existing shares, and the estimated value per security is $0.235 AUD, bringing the total ordinary shares on issue to 862,227,757.

NOVONIX Ltd. announced that four of its directors, Robert Natter, Ron Edmonds, Jean Oelwang, and Anthony Bellas, each received 195,938 direct share rights. These awards, valued at an estimated $50,944 per director, were issued on May 6, 2026, following shareholder approval at the Annual General Meeting held on April 15, 2026.

NOVONIX Limited announced the issuance of 1,371,566 unquoted Share Rights to its Directors on May 6, 2026. These share rights are part of the Directors' remuneration and were issued following shareholder approval obtained at the Annual General Meeting held on April 15, 2026.